Adjuvant 5-FU based chemotherapy for colon cancer: Match or miss the mismatch?

European Journal of Cancer

Volumn 45, Issue 3, 2009, Pages 316-317

  D'Incalci, Maurizio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; BRCA1 PROTEIN; BRCA2 PROTEIN; CISPLATIN; DOUBLE STRANDED DNA; FLUOROURACIL; TEMOZOLOMIDE;

ADJUVANT CHEMOTHERAPY; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CANCER THERAPY; COLON CANCER; DNA REPAIR; DNA REPLICATION; DRUG EFFICACY; DRUG RESISTANCE; EDITORIAL; GLIOBLASTOMA; HORMONAL THERAPY; METHYLATION; MISMATCH REPAIR; MUTATION; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION;

ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DNA MISMATCH REPAIR; FEMALE; FLUOROURACIL; HUMANS; MALE; TUMOR MARKERS, BIOLOGICAL;

EID: 59249109198     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.10.040     Document Type: Editorial

References (5)

1. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7 (2006) 335-346
2. Jover R., Zapater P., Castells A., et al. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer 45 (2009) 365-373
3. Hegi M.E., Diserens A.C., Gorlia T., et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 (2005) 997-1003
4. Catapano C.V., Broggini M., Erba E., et al. In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloroethylnitrosoureas. Cancer Res 47 (1987) 4884-4889
5. Damia G., and D'Incalci M. Targeting DNA repair as a promising approach in cancer therapy. Eur J Cancer 43 (2007) 1791-1801